-
Je něco špatně v tomto záznamu ?
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey
C. Cattaneo, J. Salmanton-García, F. Marchesi, S. El-Ashwah, F. Itri, B. Weinbergerová, M. Gomes Da Silva, M. Dargenio, J. Dávila-Valls, S. Martín-Pérez, F. Farina, J. Van Doesum, T. Valković, C. Besson, CB. Poulsen, A. López-García, P. Žák, M....
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2009
PubMed Central
od 2009
Europe PubMed Central
od 2009
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2009
PubMed
36428621
DOI
10.3390/cancers14225530
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
BACKGROUND: The outcome of patients with simultaneous diagnosis of haematological malignancies (HM) and COVID-19 is unknown and there are no specific treatment guidelines. METHODS: We describe the clinical features and outcome of a cohort of 450 patients with simultaneous diagnosis of HM and COVID-19 registered in the EPICOVIDEHA registry between March 2020 to February 2022. RESULTS: Acute leukaemia and lymphoma were the most frequent HM (35.8% and 35.1%, respectively). Overall, 343 (76.2%) patients received treatment for HM, which was delayed for longer than one month since diagnosis in 57 (16.6%). An overall response rate was observed in 140 (40.8%) patients after the first line of treatment. After a median follow-up of 35 days, overall mortality was 177/450 (39.3%); 30-day mortality was significantly higher in patients not receiving HM treatment (42.1%) than in those receiving treatment (27.4%, p = 0.004), either before and/or after COVID-19, or compared to patients receiving HM treatment at least after COVID-19 (15.2%, p < 0.001). Age, severe/critical COVID-19, ≥2 comorbidities, and lack of HM treatment were independent risk factors for mortality, whereas a lymphocyte count >500/mcl at COVID-19 onset was protective. CONCLUSIONS: HM treatment should be delivered as soon as possible for patients with simultaneous diagnosis of COVID-19 and HM requiring immediate therapy.
Aga Khan University 74000 Karachi Pakistan
ASST Grande Ospedale Metropolitano Niguarda 20162 Milan Italy
AZ KLINA 2930 Brasschaat Belgium
Azienda Ospedaliera Nazionale SS Antonio e Biagio e Cesare Arrigo 15121 Alessandria Italy
Azienda Ospedaliera San Gerardo Monza 20900 Monza Italy
Centro Hospitalar e Universitário São João 4200 319 Porto Portugal
Communicable Disease Center Hamad Medical Corporation Doha 3050 Qatar
COVID Hospital Batajnica 11000 Belgrade Serbia
Croatian Cooperative Group for Hematological Diseases 10000 Zagreb Croatia
Departament de Medicina Universitat Autònoma de Barcelona 08193 Bellaterra Spain
Department of Hematology Copenhagen University Hospital Rigshospitalet DK 2100 Copenhagen Denmark
Department of Infectious Diseases Karolinska University Hospital 17176 Stockholm Sweden
Department of Internal Medicine ADRZ 4462 RA Goes The Netherlands
Dokuz Eylul University Division of Hematology 35340 Izmir Turkey
Ematologia Con Trapianto Ospedale Dimiccoli Barletta 70051 Barletta Italy
Faculty of Medicine University of Rijeka 51000 Rijeka Croatia
Fundacion Jimenez Diaz University Hospital Health Research Institute IIS FJD 28040 Madrid Spain
German Centre for Infection Research Partner Site Bonn Cologne 50931 Cologne Germany
Hematology and Stem Cell Transplan Unit Vito Fazzi 73100 Lecce Italy
Hematology Department of Biomedicine and Prevention University of Rome Tor Vergata 00133 Rome Italy
Hematology Unit ASST Spedali Civili 25123 Brescia Italy
Hematology Unit Center for Translational Medicine Azienda USL Toscana NordOvest 55100 Livorno Italy
Hematology Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico 20122 Milan Italy
Hematology Unit Fondazione Policlinico Universitario Agostino Gemelli IRCCS 00168 Rome Italy
Hematology Unit Università Cattolica del Sacro Cuore 86100 Rome Italy
Hospital Escuela de Agudos Dr Ramón Madariaga Posadas 3736 Argentina
Hospital Nuestra Señora de Sonsoles 05004 Ávila Spain
Hospital Universitario de Navarra 31008 Iruña Pamplona Spain
Institute of Hematology and Blood Transfusion 12800 Prague Czech Republic
IRCCS Ospedale San Raffaele 20132 Milan Italy
Laikon Hospital 11527 Athens Greece
Northumbria Healthcare Newcastle NE29 8NH UK
Oncology Center Mansoura University Mansoura 35516 Egypt
Ospedale San Bortolo 36100 Vicenza Italy
Portuguese Institute of Oncology 1099 023 Lisbon Portugal
San Luigi Gonzaga Hospital 10043 Orbassano Italy
School of Medicine University of Zagreb 10000 Zagreb Croatia
Sultan Qaboos University Hospital Muscat 123 Oman
Università Milano Bicocca 20126 Milan Italy
Universitätsklinikum Hamburg Eppendorf 20251 Hamburg Germany
University Hospital Centre Rijeka 51000 Rijeka Croatia
University Hospital Centre Zagreb 10000 Zagreb Croatia
University Hospital Dubrava 10000 Zagreb Croatia
University Hospital Hradec Králové 50005 Hradec Králové Czech Republic
University Hospital Olomouc 77900 Olomouc Czech Republic
University Hospital Ostrava 70852 Ostrava Czech Republic
University Medical Center Groningen 9713 GZ Groningen The Netherlands
UOC Hematology AORN Cardarelli 80131 Naples Italy
Vall d'Hebron Institute of Oncology Vall d'Hebron Barcelona Hospital Campus 08035 Barcelona Spain
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22031313
- 003
- CZ-PrNML
- 005
- 20240418101759.0
- 007
- ta
- 008
- 230119s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/cancers14225530 $2 doi
- 035 __
- $a (PubMed)36428621
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Cattaneo, Chiara $u Hematology Unit, ASST-Spedali Civili, 25123 Brescia, Italy $1 https://orcid.org/0000000300313237
- 245 10
- $a Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey / $c C. Cattaneo, J. Salmanton-García, F. Marchesi, S. El-Ashwah, F. Itri, B. Weinbergerová, M. Gomes Da Silva, M. Dargenio, J. Dávila-Valls, S. Martín-Pérez, F. Farina, J. Van Doesum, T. Valković, C. Besson, CB. Poulsen, A. López-García, P. Žák, M. Schönlein, K. Piukovics, O. Jaksic, A. Cabirta, N. Ali, U. Sili, N. Fracchiolla, G. Dragonetti, T. Adžić-Vukičević, M. Marchetti, M. Machado, A. Glenthøj, O. Finizio, F. Demirkan, O. Blennow, MC. Tisi, AS. Omrani, M. Navrátil, Z. Ráčil, J. Novák, G. Magliano, M. Jiménez, C. Garcia-Vidal, N. Erben, MI. Del Principe, C. Buquicchio, R. Bergantim, J. Batinić, M. Al-Khabori, L. Verga, T. Szotkowski, M. Samarkos, I. Ormazabal-Vélez, S. Meers, J. Maertens, LI. Pinczés, M. Hoenigl, Ľ. Drgoňa, A. Cuccaro, YM. Bilgin, A. Aujayeb, L. Rahimli, S. Gräfe, M. Sciumè, M. Mladenović, GM. Çolak, MV. Sacchi, A. Nordlander, C. Berg Venemyr, M. Hanáková, N. García-Poutón, Z. Emarah, GPM. Zambrotta, R. Nunes Rodrigues, R. Cordoba, GA. Méndez, MM. Biernat, OA. Cornely, L. Pagano
- 520 9_
- $a BACKGROUND: The outcome of patients with simultaneous diagnosis of haematological malignancies (HM) and COVID-19 is unknown and there are no specific treatment guidelines. METHODS: We describe the clinical features and outcome of a cohort of 450 patients with simultaneous diagnosis of HM and COVID-19 registered in the EPICOVIDEHA registry between March 2020 to February 2022. RESULTS: Acute leukaemia and lymphoma were the most frequent HM (35.8% and 35.1%, respectively). Overall, 343 (76.2%) patients received treatment for HM, which was delayed for longer than one month since diagnosis in 57 (16.6%). An overall response rate was observed in 140 (40.8%) patients after the first line of treatment. After a median follow-up of 35 days, overall mortality was 177/450 (39.3%); 30-day mortality was significantly higher in patients not receiving HM treatment (42.1%) than in those receiving treatment (27.4%, p = 0.004), either before and/or after COVID-19, or compared to patients receiving HM treatment at least after COVID-19 (15.2%, p < 0.001). Age, severe/critical COVID-19, ≥2 comorbidities, and lack of HM treatment were independent risk factors for mortality, whereas a lymphocyte count >500/mcl at COVID-19 onset was protective. CONCLUSIONS: HM treatment should be delivered as soon as possible for patients with simultaneous diagnosis of COVID-19 and HM requiring immediate therapy.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Salmanton-García, Jon $u University of Cologne, Faculty of Medicine, University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), 50931 Cologne, Germany $u University of Cologne, Faculty of Medicine, University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), 50931 Cologne, Germany $1 https://orcid.org/0000000267668297
- 700 1_
- $a Marchesi, Francesco $u Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy $1 https://orcid.org/0000000163532272
- 700 1_
- $a El-Ashwah, Shaimaa $u Oncology Center, Mansoura University, Mansoura 35516, Egypt $1 https://orcid.org/0000000322101534
- 700 1_
- $a Itri, Federico $u San Luigi Gonzaga Hospital, 10043 Orbassano, Italy $1 https://orcid.org/0000000235325281
- 700 1_
- $a Weinbergerová, Barbora $u Masaryk University and University Hospital Brno-Department of Internal Medicine, Hematology and Oncology, 62500 Brno, Czech Republic
- 700 1_
- $a Gomes Da Silva, Maria $u Portuguese Institute of Oncology, 1099-023 Lisbon, Portugal $1 https://orcid.org/0000000269932450
- 700 1_
- $a Dargenio, Michelina $u Hematology and Stem Cell Transplan Unit, Vito Fazzi, 73100 Lecce, Italy
- 700 1_
- $a Dávila-Valls, Julio $u Hospital Nuestra Señora de Sonsoles, 05004 Ávila, Spain $1 https://orcid.org/0000000251852073
- 700 1_
- $a Martín-Pérez, Sonia $u Hospital Nuestra Señora de Sonsoles, 05004 Ávila, Spain
- 700 1_
- $a Farina, Francesca $u IRCCS Ospedale San Raffaele, 20132 Milan, Italy $1 https://orcid.org/0000000251246970
- 700 1_
- $a Van Doesum, Jaap $u University Medical Center Groningen, 9713 GZ Groningen, The Netherlands
- 700 1_
- $a Valković, Toni $u University Hospital Centre Rijeka, 51000 Rijeka, Croatia $u Croatian Cooperative Group for Hematological Diseases (CROHEM), 10000 Zagreb, Croatia $u Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia
- 700 1_
- $a Besson, Caroline $u Centre Hospitalier de Versailles, Le Chesnay, Université Paris-Saclay, UVSQ, Inserm, Équipe "Exposome et Hérédité", CESP, 94800 Villejuif, France $1 https://orcid.org/0000000343647173
- 700 1_
- $a Poulsen, Christian Bjørn $u Zealand University Hospital, 4000 Roskilde, Denmark $1 https://orcid.org/0000000197851378
- 700 1_
- $a López-García, Alberto $u Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, 28040 Madrid, Spain $1 https://orcid.org/0000000253545261
- 700 1_
- $a Žák, Pavel $u University Hospital Hradec Králové, 50005 Hradec Králové, Czech Republic
- 700 1_
- $a Schönlein, Martin $u Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany $1 https://orcid.org/0000000210100975
- 700 1_
- $a Piukovics, Klára $u Department of Internal Medicine, South Division, Faculty of Medicine University of Szeged, 6720 Szeged, Hungary
- 700 1_
- $a Jaksic, Ozren $u University Hospital Dubrava, 10000 Zagreb, Croatia
- 700 1_
- $a Cabirta, Alba $u Department of Hematology, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, 08193 Barcelona, Spain $u Departament de Medicina, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain $1 https://orcid.org/0000000171988894
- 700 1_
- $a Ali, Natasha $u Aga Khan University, 74000 Karachi, Pakistan $1 https://orcid.org/000000034990330X
- 700 1_
- $a Sili, Uluhan $u Department of Infectious Diseases and Clinical Microbiology, School of Medicine, Marmara University, 34854 Istanbul, Turkey $1 https://orcid.org/0000000299399298
- 700 1_
- $a Fracchiolla, Nicola $u Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy $1 https://orcid.org/0000000289828079
- 700 1_
- $a Dragonetti, Giulia $u Hematology Unit, Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, 00168 Rome, Italy $1 https://orcid.org/0000000317756333
- 700 1_
- $a Adžić-Vukičević, Tatjana $u COVID Hospital "Batajnica", 11000 Belgrade, Serbia
- 700 1_
- $a Marchetti, Monia $u Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo, 15121 Alessandria, Italy $1 https://orcid.org/0000000176150572
- 700 1_
- $a Machado, Marina $u Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, 28009 Madrid, Spain
- 700 1_
- $a Glenthøj, Andreas $u Department of Hematology, Copenhagen University Hospital-Rigshospitalet, DK-2100 Copenhagen, Denmark
- 700 1_
- $a Finizio, Olimpia $u UOC Hematology, AORN Cardarelli, 80131 Naples, Italy
- 700 1_
- $a Demirkan, Fatih, $d 1965- $u Dokuz Eylul University, Division of Hematology, 35340 Izmir, Turkey $7 xx0316387
- 700 1_
- $a Blennow, Ola $u Department of Infectious Diseases, Karolinska University Hospital, 17176 Stockholm, Sweden
- 700 1_
- $a Tisi, Maria Chiara $u Ospedale San Bortolo, 36100 Vicenza, Italy
- 700 1_
- $a Omrani, Ali S $u Communicable Disease Center, Hamad Medical Corporation, Doha 3050, Qatar $1 https://orcid.org/0000000153096358
- 700 1_
- $a Navrátil, Milan $u University Hospital Ostrava, 70852 Ostrava, Czech Republic $1 https://orcid.org/0000000220671253
- 700 1_
- $a Ráčil, Zdeněk $u Institute of Hematology and Blood Transfusion, 12800 Prague, Czech Republic
- 700 1_
- $a Novák, Jan $u Department of Hematology, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, 12808 Prague, Czech Republic
- 700 1_
- $a Magliano, Gabriele $u ASST Grande Ospedale Metropolitano Niguarda, 20162 Milan, Italy $1 https://orcid.org/0000000291291530
- 700 1_
- $a Jiménez, Moraima $u Department of Hematology, University Hospital Vall d'Hebron, Experimental Hematology, 08035 Barcelona, Spain $u Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain
- 700 1_
- $a Garcia-Vidal, Carolina $u Department of Infectious Diseases, Hospital Clinic de Barcelona, University of Barcelona, IDIBAPS, 08035 Barcelona, Spain
- 700 1_
- $a Erben, Nurettin $u Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine Eskisehir Osmangazi University, 26040 Eskisehir, Turkey
- 700 1_
- $a Del Principe, Maria Ilaria $u Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy
- 700 1_
- $a Buquicchio, Caterina $u Ematologia Con Trapianto, Ospedale Dimiccoli Barletta, 70051 Barletta, Italy
- 700 1_
- $a Bergantim, Rui $u Centro Hospitalar e Universitário São João, 4200-319 Porto, Portugal $1 https://orcid.org/0000000278119509
- 700 1_
- $a Batinić, Josip $u University Hospital Centre Zagreb, 10000 Zagreb, Croatia $u Croatian Cooperative Group for Hematological Diseases (KROHEM), 10000 Zagreb, Croatia $u School of Medicine University of Zagreb, 10000 Zagreb, Croatia
- 700 1_
- $a Al-Khabori, Murtadha $u Sultan Qaboos University Hospital, Muscat 123, Oman $1 https://orcid.org/0000000229378838
- 700 1_
- $a Verga, Luisa $u Azienda Ospedaliera San Gerardo-Monza, 20900 Monza, Italy $u Università Milano-Bicocca, 20126 Milan, Italy
- 700 1_
- $a Szotkowski, Tomáš $u University Hospital Olomouc, 77900 Olomouc, Czech Republic
- 700 1_
- $a Samarkos, Michail $u Laikon Hospital, 11527 Athens, Greece $1 https://orcid.org/0000000196309712
- 700 1_
- $a Ormazabal-Vélez, Irati $u Hospital Universitario de Navarra, 31008 Iruña-Pamplona, Spain $1 https://orcid.org/0000000311415546
- 700 1_
- $a Meers, Stef $u AZ KLINA, 2930 Brasschaat, Belgium
- 700 1_
- $a Maertens, Johan $u KU Leuven, 3000 Leuven, Belgium $1 https://orcid.org/0000000342575980
- 700 1_
- $a Pinczés, László Imre $u Division of Hematology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary $1 https://orcid.org/0000000304531709
- 700 1_
- $a Hoenigl, Martin $u Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, CA 92093, USA $u Clinical and Translational Fungal-Working Group, University of California San Diego, La Jolla, CA 92093, USA $u Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, A-8036 Graz, Austria $1 https://orcid.org/0000000216532824
- 700 1_
- $a Drgoňa, Ľuboš $u Department of Oncohematology, Comenius University and National Cancer Institute, 81499 Bratislava, Slovakia
- 700 1_
- $a Cuccaro, Annarosa $u Hematology Unit, Center for Translational Medicine, Azienda USL Toscana NordOvest, 55100 Livorno, Italy $1 https://orcid.org/0000000202371839
- 700 1_
- $a Bilgin, Yavuz M $u Department of Internal Medicine, ADRZ, 4462 RA Goes, The Netherlands
- 700 1_
- $a Aujayeb, Avinash $u Northumbria Healthcare, Newcastle NE29 8NH, UK $1 https://orcid.org/0000000208595550
- 700 1_
- $a Rahimli, Laman $u University of Cologne, Faculty of Medicine, University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), 50931 Cologne, Germany $u University of Cologne, Faculty of Medicine, University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), 50931 Cologne, Germany
- 700 1_
- $a Gräfe, Stefanie $u University of Cologne, Faculty of Medicine, University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), 50931 Cologne, Germany $u University of Cologne, Faculty of Medicine, University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), 50931 Cologne, Germany $u Universitätsklinikum Hamburg Eppendorf, 20251 Hamburg, Germany
- 700 1_
- $a Sciumè, Mariarita $u Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy $1 https://orcid.org/0000000179584966
- 700 1_
- $a Mladenović, Miloš $u COVID Hospital "Batajnica", 11000 Belgrade, Serbia $u Clinic for Orthopedic Surgery and Traumatology, University Clinical Center of Serbia, 11000 Belgrade, Serbia
- 700 1_
- $a Çolak, Gökçe Melis $u Department of Infectious Diseases and Clinical Microbiology, School of Medicine, Marmara University, 34854 Istanbul, Turkey $1 https://orcid.org/000000019065374X
- 700 1_
- $a Sacchi, Maria Vittoria $u Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo, 15121 Alessandria, Italy
- 700 1_
- $a Nordlander, Anna $u Department of Infectious Diseases, Karolinska University Hospital, 17176 Stockholm, Sweden
- 700 1_
- $a Berg Venemyr, Caroline $u Department of Hematology, Copenhagen University Hospital-Rigshospitalet, DK-2100 Copenhagen, Denmark
- 700 1_
- $a Hanáková, Michaela $u Institute of Hematology and Blood Transfusion, 12800 Prague, Czech Republic
- 700 1_
- $a García-Poutón, Nicole $u Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain
- 700 1_
- $a Emarah, Ziad $u Oncology Center, Mansoura University, Mansoura 35516, Egypt $1 https://orcid.org/0000000306222598
- 700 1_
- $a Zambrotta, Giovanni Paolo Maria $u Sultan Qaboos University Hospital, Muscat 123, Oman $u Azienda Ospedaliera San Gerardo-Monza, 20900 Monza, Italy $1 https://orcid.org/0000000286122994
- 700 1_
- $a Nunes Rodrigues, Raquel $u Portuguese Institute of Oncology, 1099-023 Lisbon, Portugal
- 700 1_
- $a Cordoba, Raul $u Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, 28040 Madrid, Spain
- 700 1_
- $a Méndez, Gustavo-Adolfo $u Hospital Escuela de Agudos Dr. Ramón Madariaga, Posadas 3736, Argentina
- 700 1_
- $a Biernat, Monika M $u Department of Haematology, Blood Neoplasms, and Bone Marrow Transplantation, Wroclaw Medical University, 50-425 Wroclaw, Poland
- 700 1_
- $a Cornely, Oliver A $u University of Cologne, Faculty of Medicine, University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), 50931 Cologne, Germany $u University of Cologne, Faculty of Medicine, University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), 50931 Cologne, Germany $u University of Cologne, Faculty of Medicine, University Hospital Cologne, Clinical Trials Centre Cologne (ZKS Köln), 50931 Cologne, Germany $u German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, 50931 Cologne, Germany $1 https://orcid.org/0000000195993137
- 700 1_
- $a Pagano, Livio $u Hematology Unit, Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, 00168 Rome, Italy $u Hematology Unit, Università Cattolica del Sacro Cuore, 86100 Rome, Italy $1 https://orcid.org/000000018287928X
- 773 0_
- $w MED00173178 $t Cancers $x 2072-6694 $g Roč. 14, č. 22 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36428621 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230119 $b ABA008
- 991 __
- $a 20240418101753 $b ABA008
- 999 __
- $a ok $b bmc $g 1889453 $s 1182646
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2022 $b 14 $c 22 $e 20221110 $i 2072-6694 $m Cancers $n Cancers $x MED00173178
- LZP __
- $a Pubmed-20230119
